Care Rail

← Medical · All 20 for COVID-19 (residual / endemic)

Switzerland

COVID-19 (residual / endemic) · Infectious

High spend, high access, canton variation. Vaccination + antivirals for high-risk; hospital surge plans residual. Infectious pathway via Mandatory private insurance.

Rank in this country#24
Share of deaths1.1%
Master rank#25
System quality rank#11

Access & coverage

Mandatory private insurance

Mandatory private insurance; high premiums; broad benefit baskets

Treatment

  • Antivirals / antibiotics per stewardship rules
  • Hospital pathways for severe pneumonia / sepsis
  • Antiretroviral or TB regimens with public-health follow-up

Prevention

  • National immunization schedules
  • Surveillance, outbreak response, infection control in hospitals
  • Targeted screening (TB, HIV, hep) for risk groups

Lifestyle

  • Hygiene, ventilation awareness, staying home when infectious
  • Vaccination uptake as a social norm
  • Safer sex / harm reduction where relevant

What stands out here

Same broad infectious toolkit as peers — differences are coverage rules, wait times, prices, and follow-through.

vs master: +0.0 percentage points vs Top 20 average share.